Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2007010242) USE OF A NORADRENERGIC AGONIST, E.G. GUANFACINE, FOR THE TREATMENT OF COGNITIVE DISORDERS
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2007/010242 International Application No.: PCT/GB2006/002669
Publication Date: 25.01.2007 International Filing Date: 18.07.2006
IPC:
A61K 31/165 (2006.01) ,A61P 25/28 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
16
Amides, e.g. hydroxamic acids
165
having aromatic rings, e.g. colchicine, atenolol, progabide
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25
Drugs for disorders of the nervous system
28
for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Applicants:
IMPERIAL COLLEGE INNOVATIONS LIMITED [GB/GB]; Electrical and Electronic Engineering Building Level 12 Imperial College Exhibition Road London SW7 2AZ, GB (AllExceptUS)
HUSAIN, Masud [GB/GB]; GB (UsOnly)
PARTON, Andrew, David [GB/GB]; GB (UsOnly)
MALHOTRA, Paresh, Arjun [GB/GB]; GB (UsOnly)
Inventors:
HUSAIN, Masud; GB
PARTON, Andrew, David; GB
MALHOTRA, Paresh, Arjun; GB
Agent:
LEE, Nicholas, John ; Kilburn & Strode 20 Red Lion Street London WC1R 4PJ, GB
Priority Data:
0514687.318.07.2005GB
0516373.809.08.2005GB
Title (EN) USE OF A NORADRENERGIC AGONIST, E.G. GUANFACINE, FOR THE TREATMENT OF COGNITIVE DISORDERS
(FR) UTILISATION D'UN AGONISTE NORADRENERGIQUE, A SAVOIR, LA GUANFACINE POUR LE TRAITEMENT DE TROUBLES COGNITIFS
Abstract:
(EN) The present invention relates to the use of a noradrenergic agonist for the treatment of a patient with a cognitive disorder resulting from acquired brain damage, wherein the cognitive disorder includes, for example, hemi-spatial neglect.
(FR) La présente invention concerne l'utilisation d'un agoniste noradrénergique dans le traitement d'un patient souffrant d'un trouble cognitif provenant d'un accident cérébral acquis, ledit trouble cognitif comprenant, par exemple, une hémi-négligence spatiale.
front page image
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
US20090076156